Goitre involution: iodide as an hypervascularity antagonist
Jean-Baptiste Rognoni,
Laboratoire de Biochimie, Section Endocrinologie Cellulaire, CHU Nord, Marseille, France
Claude Penel,
Laboratoire de Biochimie, Section Endocrinologie Cellulaire, CHU Nord, Marseille, France
Françoise Ducret,
Laboratoire de Biochimie, Section Endocrinologie Cellulaire, CHU Nord, Marseille, France
Abstract
Goitre involution was studied in rats during an iodide refeeding period. A first phase (day 0-8) was characterised by a dramatical regression of the hypervascularity, which was induced by plasma iodide, but was thyrotropin independent. During a second phase (day 8-90), follicle formation occurred, associated with the increase of the interstitial tissue in the gland and controlled by the plasma thyrotropin concentration.
Om dit artikel te citeren:
Jean-Baptiste Rognoni, Claude Penel & Françoise Ducret, «Goitre involution: iodide as an hypervascularity antagonist», Acta Stereologica [En ligne], Volume 2 (1983), Number 1 - Apr. 1983, 145-150 URL : https://popups.uliege.be/0351-580x/index.php?id=4128.